Equities Research Analysts’ upgrades for Monday, August 3rd:
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. They currently have $420.00 target price on the stock.
American Water Works (NYSE:AWK) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.
Bullish (NYSE:BLSH) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
CareDx (NASDAQ:CDNA) was upgraded by analysts at Craig Hallum from a hold rating to a buy rating. They currently have $64.00 price target on the stock.
Ennis (NYSE:EBF) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Fortinet (NASDAQ:FTNT) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Genius Sports (NYSE:GENI) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.
inTEST (NYSE:INTT) was upgraded by analysts at Northland Securities from a market perform rating to an outperform rating. The firm currently has $15.00 price target on the stock.
Ingersoll Rand (NYSE:IR) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. Stifel Nicolaus currently has $101.00 price target on the stock.
LyondellBasell Industries (NYSE:LYB) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $80.00 target price on the stock, up from their previous target price of $75.00.
Proto Labs (NYSE:PRLB) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. They currently have $87.00 price target on the stock.
Ralliant (NYSE:RAL) was upgraded by analysts at Wall Street Zen from a hold rating to a strong-buy rating.
Starbucks (NASDAQ:SBUX) was upgraded by analysts at Melius Research from a sell rating to a hold rating.
Texas Capital Bancshares (NASDAQ:TCBI) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. The firm currently has $100.00 price target on the stock.
Tenet Healthcare (NYSE:THC) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.
Receive News & Ratings for Alnylam Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
